The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Furosemide API Market Research Report 2025
Synopsis
The global market for Furosemide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Furosemide API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Furosemide API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Furosemide API include Kalintis Healthcare Pvt Ltd, Curia India Private Limited, Sri Krishna Pharmaceuticals Ltd, Euroapi Germany Gmbh, Ipca Laboratories Ltd, Fis Fabbrica Italiana Sintetici Spa, Olon S.P.A., Teva Pharmaceutical Industries Ltd, Mangalam Drugs & Organics Ltd., Assia Chemical Industries Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Furosemide API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Furosemide API.
The Furosemide API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Furosemide API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Furosemide API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kalintis Healthcare Pvt Ltd
Curia India Private Limited
Sri Krishna Pharmaceuticals Ltd
Euroapi Germany Gmbh
Ipca Laboratories Ltd
Fis Fabbrica Italiana Sintetici Spa
Olon S.P.A.
Teva Pharmaceutical Industries Ltd
Mangalam Drugs & Organics Ltd.
Assia Chemical Industries Ltd
Guangzhou Baiyunshan Pharmaceutical
Beijing Taiyang Pharmaceutical Industry
NORTHEAST Pharmaceutical Group
by Type
Purity≥99%
Purity<99%
by Application
Injection
Tablet
Solution
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Furosemide API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Furosemide API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Furosemide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
The global market for Furosemide API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Furosemide API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Furosemide API is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Furosemide API include Kalintis Healthcare Pvt Ltd, Curia India Private Limited, Sri Krishna Pharmaceuticals Ltd, Euroapi Germany Gmbh, Ipca Laboratories Ltd, Fis Fabbrica Italiana Sintetici Spa, Olon S.P.A., Teva Pharmaceutical Industries Ltd, Mangalam Drugs & Organics Ltd., Assia Chemical Industries Ltd, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Furosemide API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Furosemide API.
The Furosemide API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Furosemide API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Furosemide API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Kalintis Healthcare Pvt Ltd
Curia India Private Limited
Sri Krishna Pharmaceuticals Ltd
Euroapi Germany Gmbh
Ipca Laboratories Ltd
Fis Fabbrica Italiana Sintetici Spa
Olon S.P.A.
Teva Pharmaceutical Industries Ltd
Mangalam Drugs & Organics Ltd.
Assia Chemical Industries Ltd
Guangzhou Baiyunshan Pharmaceutical
Beijing Taiyang Pharmaceutical Industry
NORTHEAST Pharmaceutical Group
by Type
Purity≥99%
Purity<99%
by Application
Injection
Tablet
Solution
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Rest of Europe
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Furosemide API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Furosemide API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Furosemide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Furosemide API Market Overview
1.1 Product Definition
1.2 Furosemide API by Type
1.2.1 Global Furosemide API Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 Purity≥99%
1.2.3 Purity<99%
1.3 Furosemide API by Application
1.3.1 Global Furosemide API Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Injection
1.3.3 Tablet
1.3.4 Solution
1.4 Global Market Growth Prospects
1.4.1 Global Furosemide API Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Furosemide API Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Furosemide API Production Estimates and Forecasts (2020-2031)
1.4.4 Global Furosemide API Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Furosemide API Production Market Share by Manufacturers (2020-2025)
2.2 Global Furosemide API Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Furosemide API, Industry Ranking, 2023 VS 2024
2.4 Global Furosemide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Furosemide API Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Furosemide API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Furosemide API, Product Offered and Application
2.8 Global Key Manufacturers of Furosemide API, Date of Enter into This Industry
2.9 Furosemide API Market Competitive Situation and Trends
2.9.1 Furosemide API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Furosemide API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Furosemide API Production by Region
3.1 Global Furosemide API Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Furosemide API Production Value by Region (2020-2031)
3.2.1 Global Furosemide API Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Furosemide API by Region (2026-2031)
3.3 Global Furosemide API Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Furosemide API Production Volume by Region (2020-2031)
3.4.1 Global Furosemide API Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Furosemide API by Region (2026-2031)
3.5 Global Furosemide API Market Price Analysis by Region (2020-2025)
3.6 Global Furosemide API Production and Value, Year-over-Year Growth
3.6.1 North America Furosemide API Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Furosemide API Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Furosemide API Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Furosemide API Production Value Estimates and Forecasts (2020-2031)
4 Furosemide API Consumption by Region
4.1 Global Furosemide API Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Furosemide API Consumption by Region (2020-2031)
4.2.1 Global Furosemide API Consumption by Region (2020-2025)
4.2.2 Global Furosemide API Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Furosemide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Furosemide API Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Furosemide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Furosemide API Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Furosemide API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Furosemide API Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Furosemide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Furosemide API Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Furosemide API Production by Type (2020-2031)
5.1.1 Global Furosemide API Production by Type (2020-2025)
5.1.2 Global Furosemide API Production by Type (2026-2031)
5.1.3 Global Furosemide API Production Market Share by Type (2020-2031)
5.2 Global Furosemide API Production Value by Type (2020-2031)
5.2.1 Global Furosemide API Production Value by Type (2020-2025)
5.2.2 Global Furosemide API Production Value by Type (2026-2031)
5.2.3 Global Furosemide API Production Value Market Share by Type (2020-2031)
5.3 Global Furosemide API Price by Type (2020-2031)
6 Segment by Application
6.1 Global Furosemide API Production by Application (2020-2031)
6.1.1 Global Furosemide API Production by Application (2020-2025)
6.1.2 Global Furosemide API Production by Application (2026-2031)
6.1.3 Global Furosemide API Production Market Share by Application (2020-2031)
6.2 Global Furosemide API Production Value by Application (2020-2031)
6.2.1 Global Furosemide API Production Value by Application (2020-2025)
6.2.2 Global Furosemide API Production Value by Application (2026-2031)
6.2.3 Global Furosemide API Production Value Market Share by Application (2020-2031)
6.3 Global Furosemide API Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Kalintis Healthcare Pvt Ltd
7.1.1 Kalintis Healthcare Pvt Ltd Furosemide API Company Information
7.1.2 Kalintis Healthcare Pvt Ltd Furosemide API Product Portfolio
7.1.3 Kalintis Healthcare Pvt Ltd Furosemide API Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Kalintis Healthcare Pvt Ltd Main Business and Markets Served
7.1.5 Kalintis Healthcare Pvt Ltd Recent Developments/Updates
7.2 Curia India Private Limited
7.2.1 Curia India Private Limited Furosemide API Company Information
7.2.2 Curia India Private Limited Furosemide API Product Portfolio
7.2.3 Curia India Private Limited Furosemide API Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Curia India Private Limited Main Business and Markets Served
7.2.5 Curia India Private Limited Recent Developments/Updates
7.3 Sri Krishna Pharmaceuticals Ltd
7.3.1 Sri Krishna Pharmaceuticals Ltd Furosemide API Company Information
7.3.2 Sri Krishna Pharmaceuticals Ltd Furosemide API Product Portfolio
7.3.3 Sri Krishna Pharmaceuticals Ltd Furosemide API Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Sri Krishna Pharmaceuticals Ltd Main Business and Markets Served
7.3.5 Sri Krishna Pharmaceuticals Ltd Recent Developments/Updates
7.4 Euroapi Germany Gmbh
7.4.1 Euroapi Germany Gmbh Furosemide API Company Information
7.4.2 Euroapi Germany Gmbh Furosemide API Product Portfolio
7.4.3 Euroapi Germany Gmbh Furosemide API Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Euroapi Germany Gmbh Main Business and Markets Served
7.4.5 Euroapi Germany Gmbh Recent Developments/Updates
7.5 Ipca Laboratories Ltd
7.5.1 Ipca Laboratories Ltd Furosemide API Company Information
7.5.2 Ipca Laboratories Ltd Furosemide API Product Portfolio
7.5.3 Ipca Laboratories Ltd Furosemide API Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Ipca Laboratories Ltd Main Business and Markets Served
7.5.5 Ipca Laboratories Ltd Recent Developments/Updates
7.6 Fis Fabbrica Italiana Sintetici Spa
7.6.1 Fis Fabbrica Italiana Sintetici Spa Furosemide API Company Information
7.6.2 Fis Fabbrica Italiana Sintetici Spa Furosemide API Product Portfolio
7.6.3 Fis Fabbrica Italiana Sintetici Spa Furosemide API Production, Value, Price and Gross Margin (2020-2025)
7.6.4 Fis Fabbrica Italiana Sintetici Spa Main Business and Markets Served
7.6.5 Fis Fabbrica Italiana Sintetici Spa Recent Developments/Updates
7.7 Olon S.P.A.
7.7.1 Olon S.P.A. Furosemide API Company Information
7.7.2 Olon S.P.A. Furosemide API Product Portfolio
7.7.3 Olon S.P.A. Furosemide API Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Olon S.P.A. Main Business and Markets Served
7.7.5 Olon S.P.A. Recent Developments/Updates
7.8 Teva Pharmaceutical Industries Ltd
7.8.1 Teva Pharmaceutical Industries Ltd Furosemide API Company Information
7.8.2 Teva Pharmaceutical Industries Ltd Furosemide API Product Portfolio
7.8.3 Teva Pharmaceutical Industries Ltd Furosemide API Production, Value, Price and Gross Margin (2020-2025)
7.8.4 Teva Pharmaceutical Industries Ltd Main Business and Markets Served
7.8.5 Teva Pharmaceutical Industries Ltd Recent Developments/Updates
7.9 Mangalam Drugs & Organics Ltd.
7.9.1 Mangalam Drugs & Organics Ltd. Furosemide API Company Information
7.9.2 Mangalam Drugs & Organics Ltd. Furosemide API Product Portfolio
7.9.3 Mangalam Drugs & Organics Ltd. Furosemide API Production, Value, Price and Gross Margin (2020-2025)
7.9.4 Mangalam Drugs & Organics Ltd. Main Business and Markets Served
7.9.5 Mangalam Drugs & Organics Ltd. Recent Developments/Updates
7.10 Assia Chemical Industries Ltd
7.10.1 Assia Chemical Industries Ltd Furosemide API Company Information
7.10.2 Assia Chemical Industries Ltd Furosemide API Product Portfolio
7.10.3 Assia Chemical Industries Ltd Furosemide API Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Assia Chemical Industries Ltd Main Business and Markets Served
7.10.5 Assia Chemical Industries Ltd Recent Developments/Updates
7.11 Guangzhou Baiyunshan Pharmaceutical
7.11.1 Guangzhou Baiyunshan Pharmaceutical Furosemide API Company Information
7.11.2 Guangzhou Baiyunshan Pharmaceutical Furosemide API Product Portfolio
7.11.3 Guangzhou Baiyunshan Pharmaceutical Furosemide API Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Guangzhou Baiyunshan Pharmaceutical Main Business and Markets Served
7.11.5 Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
7.12 Beijing Taiyang Pharmaceutical Industry
7.12.1 Beijing Taiyang Pharmaceutical Industry Furosemide API Company Information
7.12.2 Beijing Taiyang Pharmaceutical Industry Furosemide API Product Portfolio
7.12.3 Beijing Taiyang Pharmaceutical Industry Furosemide API Production, Value, Price and Gross Margin (2020-2025)
7.12.4 Beijing Taiyang Pharmaceutical Industry Main Business and Markets Served
7.12.5 Beijing Taiyang Pharmaceutical Industry Recent Developments/Updates
7.13 NORTHEAST Pharmaceutical Group
7.13.1 NORTHEAST Pharmaceutical Group Furosemide API Company Information
7.13.2 NORTHEAST Pharmaceutical Group Furosemide API Product Portfolio
7.13.3 NORTHEAST Pharmaceutical Group Furosemide API Production, Value, Price and Gross Margin (2020-2025)
7.13.4 NORTHEAST Pharmaceutical Group Main Business and Markets Served
7.13.5 NORTHEAST Pharmaceutical Group Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Furosemide API Industry Chain Analysis
8.2 Furosemide API Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Furosemide API Production Mode & Process Analysis
8.4 Furosemide API Sales and Marketing
8.4.1 Furosemide API Sales Channels
8.4.2 Furosemide API Distributors
8.5 Furosemide API Customer Analysis
9 Furosemide API Market Dynamics
9.1 Furosemide API Industry Trends
9.2 Furosemide API Market Drivers
9.3 Furosemide API Market Challenges
9.4 Furosemide API Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of TablesList of Tables
Table 1. Global Furosemide API Market Value by Type, (US$ Million) & (2024 VS 2031)
Table 2. Global Furosemide API Market Value by Application, (US$ Million) & (2024 VS 2031)
Table 3. Global Furosemide API Production Capacity (Tons) by Manufacturers in 2024
Table 4. Global Furosemide API Production by Manufacturers (2020-2025) & (Tons)
Table 5. Global Furosemide API Production Market Share by Manufacturers (2020-2025)
Table 6. Global Furosemide API Production Value by Manufacturers (2020-2025) & (US$ Million)
Table 7. Global Furosemide API Production Value Share by Manufacturers (2020-2025)
Table 8. Global Key Players of Furosemide API, Industry Ranking, 2023 VS 2024
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Furosemide API as of 2024)
Table 10. Global Market Furosemide API Average Price by Manufacturers (US$/Ton) & (2020-2025)
Table 11. Global Key Manufacturers of Furosemide API, Manufacturing Base Distribution and Headquarters
Table 12. Global Key Manufacturers of Furosemide API, Product Offered and Application
Table 13. Global Key Manufacturers of Furosemide API, Date of Enter into This Industry
Table 14. Global Furosemide API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Furosemide API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Furosemide API Production Value (US$ Million) by Region (2020-2025)
Table 18. Global Furosemide API Production Value Market Share by Region (2020-2025)
Table 19. Global Furosemide API Production Value (US$ Million) Forecast by Region (2026-2031)
Table 20. Global Furosemide API Production Value Market Share Forecast by Region (2026-2031)
Table 21. Global Furosemide API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Table 22. Global Furosemide API Production (Tons) by Region (2020-2025)
Table 23. Global Furosemide API Production Market Share by Region (2020-2025)
Table 24. Global Furosemide API Production (Tons) Forecast by Region (2026-2031)
Table 25. Global Furosemide API Production Market Share Forecast by Region (2026-2031)
Table 26. Global Furosemide API Market Average Price (US$/Ton) by Region (2020-2025)
Table 27. Global Furosemide API Market Average Price (US$/Ton) by Region (2026-2031)
Table 28. Global Furosemide API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 29. Global Furosemide API Consumption by Region (2020-2025) & (Tons)
Table 30. Global Furosemide API Consumption Market Share by Region (2020-2025)
Table 31. Global Furosemide API Forecasted Consumption by Region (2026-2031) & (Tons)
Table 32. Global Furosemide API Forecasted Consumption Market Share by Region (2026-2031)
Table 33. North America Furosemide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 34. North America Furosemide API Consumption by Country (2020-2025) & (Tons)
Table 35. North America Furosemide API Consumption by Country (2026-2031) & (Tons)
Table 36. Europe Furosemide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 37. Europe Furosemide API Consumption by Country (2020-2025) & (Tons)
Table 38. Europe Furosemide API Consumption by Country (2026-2031) & (Tons)
Table 39. Asia Pacific Furosemide API Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
Table 40. Asia Pacific Furosemide API Consumption by Region (2020-2025) & (Tons)
Table 41. Asia Pacific Furosemide API Consumption by Region (2026-2031) & (Tons)
Table 42. Latin America, Middle East & Africa Furosemide API Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
Table 43. Latin America, Middle East & Africa Furosemide API Consumption by Country (2020-2025) & (Tons)
Table 44. Latin America, Middle East & Africa Furosemide API Consumption by Country (2026-2031) & (Tons)
Table 45. Global Furosemide API Production (Tons) by Type (2020-2025)
Table 46. Global Furosemide API Production (Tons) by Type (2026-2031)
Table 47. Global Furosemide API Production Market Share by Type (2020-2025)
Table 48. Global Furosemide API Production Market Share by Type (2026-2031)
Table 49. Global Furosemide API Production Value (US$ Million) by Type (2020-2025)
Table 50. Global Furosemide API Production Value (US$ Million) by Type (2026-2031)
Table 51. Global Furosemide API Production Value Market Share by Type (2020-2025)
Table 52. Global Furosemide API Production Value Market Share by Type (2026-2031)
Table 53. Global Furosemide API Price (US$/Ton) by Type (2020-2025)
Table 54. Global Furosemide API Price (US$/Ton) by Type (2026-2031)
Table 55. Global Furosemide API Production (Tons) by Application (2020-2025)
Table 56. Global Furosemide API Production (Tons) by Application (2026-2031)
Table 57. Global Furosemide API Production Market Share by Application (2020-2025)
Table 58. Global Furosemide API Production Market Share by Application (2026-2031)
Table 59. Global Furosemide API Production Value (US$ Million) by Application (2020-2025)
Table 60. Global Furosemide API Production Value (US$ Million) by Application (2026-2031)
Table 61. Global Furosemide API Production Value Market Share by Application (2020-2025)
Table 62. Global Furosemide API Production Value Market Share by Application (2026-2031)
Table 63. Global Furosemide API Price (US$/Ton) by Application (2020-2025)
Table 64. Global Furosemide API Price (US$/Ton) by Application (2026-2031)
Table 65. Kalintis Healthcare Pvt Ltd Furosemide API Company Information
Table 66. Kalintis Healthcare Pvt Ltd Furosemide API Specification and Application
Table 67. Kalintis Healthcare Pvt Ltd Furosemide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 68. Kalintis Healthcare Pvt Ltd Main Business and Markets Served
Table 69. Kalintis Healthcare Pvt Ltd Recent Developments/Updates
Table 70. Curia India Private Limited Furosemide API Company Information
Table 71. Curia India Private Limited Furosemide API Specification and Application
Table 72. Curia India Private Limited Furosemide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 73. Curia India Private Limited Main Business and Markets Served
Table 74. Curia India Private Limited Recent Developments/Updates
Table 75. Sri Krishna Pharmaceuticals Ltd Furosemide API Company Information
Table 76. Sri Krishna Pharmaceuticals Ltd Furosemide API Specification and Application
Table 77. Sri Krishna Pharmaceuticals Ltd Furosemide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 78. Sri Krishna Pharmaceuticals Ltd Main Business and Markets Served
Table 79. Sri Krishna Pharmaceuticals Ltd Recent Developments/Updates
Table 80. Euroapi Germany Gmbh Furosemide API Company Information
Table 81. Euroapi Germany Gmbh Furosemide API Specification and Application
Table 82. Euroapi Germany Gmbh Furosemide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 83. Euroapi Germany Gmbh Main Business and Markets Served
Table 84. Euroapi Germany Gmbh Recent Developments/Updates
Table 85. Ipca Laboratories Ltd Furosemide API Company Information
Table 86. Ipca Laboratories Ltd Furosemide API Specification and Application
Table 87. Ipca Laboratories Ltd Furosemide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 88. Ipca Laboratories Ltd Main Business and Markets Served
Table 89. Ipca Laboratories Ltd Recent Developments/Updates
Table 90. Fis Fabbrica Italiana Sintetici Spa Furosemide API Company Information
Table 91. Fis Fabbrica Italiana Sintetici Spa Furosemide API Specification and Application
Table 92. Fis Fabbrica Italiana Sintetici Spa Furosemide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 93. Fis Fabbrica Italiana Sintetici Spa Main Business and Markets Served
Table 94. Fis Fabbrica Italiana Sintetici Spa Recent Developments/Updates
Table 95. Olon S.P.A. Furosemide API Company Information
Table 96. Olon S.P.A. Furosemide API Specification and Application
Table 97. Olon S.P.A. Furosemide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 98. Olon S.P.A. Main Business and Markets Served
Table 99. Olon S.P.A. Recent Developments/Updates
Table 100. Teva Pharmaceutical Industries Ltd Furosemide API Company Information
Table 101. Teva Pharmaceutical Industries Ltd Furosemide API Specification and Application
Table 102. Teva Pharmaceutical Industries Ltd Furosemide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 103. Teva Pharmaceutical Industries Ltd Main Business and Markets Served
Table 104. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 105. Mangalam Drugs & Organics Ltd. Furosemide API Company Information
Table 106. Mangalam Drugs & Organics Ltd. Furosemide API Specification and Application
Table 107. Mangalam Drugs & Organics Ltd. Furosemide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 108. Mangalam Drugs & Organics Ltd. Main Business and Markets Served
Table 109. Mangalam Drugs & Organics Ltd. Recent Developments/Updates
Table 110. Assia Chemical Industries Ltd Furosemide API Company Information
Table 111. Assia Chemical Industries Ltd Furosemide API Specification and Application
Table 112. Assia Chemical Industries Ltd Furosemide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 113. Assia Chemical Industries Ltd Main Business and Markets Served
Table 114. Assia Chemical Industries Ltd Recent Developments/Updates
Table 115. Guangzhou Baiyunshan Pharmaceutical Furosemide API Company Information
Table 116. Guangzhou Baiyunshan Pharmaceutical Furosemide API Specification and Application
Table 117. Guangzhou Baiyunshan Pharmaceutical Furosemide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 118. Guangzhou Baiyunshan Pharmaceutical Main Business and Markets Served
Table 119. Guangzhou Baiyunshan Pharmaceutical Recent Developments/Updates
Table 120. Beijing Taiyang Pharmaceutical Industry Furosemide API Company Information
Table 121. Beijing Taiyang Pharmaceutical Industry Furosemide API Specification and Application
Table 122. Beijing Taiyang Pharmaceutical Industry Furosemide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 123. Beijing Taiyang Pharmaceutical Industry Main Business and Markets Served
Table 124. Beijing Taiyang Pharmaceutical Industry Recent Developments/Updates
Table 125. NORTHEAST Pharmaceutical Group Furosemide API Company Information
Table 126. NORTHEAST Pharmaceutical Group Furosemide API Specification and Application
Table 127. NORTHEAST Pharmaceutical Group Furosemide API Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
Table 128. NORTHEAST Pharmaceutical Group Main Business and Markets Served
Table 129. NORTHEAST Pharmaceutical Group Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Furosemide API Distributors List
Table 133. Furosemide API Customers List
Table 134. Furosemide API Market Trends
Table 135. Furosemide API Market Drivers
Table 136. Furosemide API Market Challenges
Table 137. Furosemide API Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Furosemide API
Figure 2. Global Furosemide API Market Value by Type, (US$ Million) & (2020-2031)
Figure 3. Global Furosemide API Market Share by Type: 2024 VS 2031
Figure 4. Purity≥99% Product Picture
Figure 5. Purity<99% Product Picture
Figure 6. Global Furosemide API Market Value by Application, (US$ Million) & (2020-2031)
Figure 7. Global Furosemide API Market Share by Application: 2024 VS 2031
Figure 8. Injection
Figure 9. Tablet
Figure 10. Solution
Figure 11. Global Furosemide API Production Value (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Furosemide API Production Value (US$ Million) & (2020-2031)
Figure 13. Global Furosemide API Production Capacity (Tons) & (2020-2031)
Figure 14. Global Furosemide API Production (Tons) & (2020-2031)
Figure 15. Global Furosemide API Average Price (US$/Ton) & (2020-2031)
Figure 16. Furosemide API Report Years Considered
Figure 17. Furosemide API Production Share by Manufacturers in 2024
Figure 18. Global Furosemide API Production Value Share by Manufacturers (2024)
Figure 19. Furosemide API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. The Global 5 and 10 Largest Players: Market Share by Furosemide API Revenue in 2024
Figure 21. Global Furosemide API Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 22. Global Furosemide API Production Value Market Share by Region: 2020 VS 2024 VS 2031
Figure 23. Global Furosemide API Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 24. Global Furosemide API Production Market Share by Region: 2020 VS 2024 VS 2031
Figure 25. North America Furosemide API Production Value (US$ Million) Growth Rate (2020-2031)
Figure 26. Europe Furosemide API Production Value (US$ Million) Growth Rate (2020-2031)
Figure 27. China Furosemide API Production Value (US$ Million) Growth Rate (2020-2031)
Figure 28. Japan Furosemide API Production Value (US$ Million) Growth Rate (2020-2031)
Figure 29. Global Furosemide API Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
Figure 30. Global Furosemide API Consumption Market Share by Region: 2020 VS 2024 VS 2031
Figure 31. North America Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 32. North America Furosemide API Consumption Market Share by Country (2020-2031)
Figure 33. U.S. Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 34. Canada Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 35. Europe Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 36. Europe Furosemide API Consumption Market Share by Country (2020-2031)
Figure 37. Germany Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 38. France Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 39. U.K. Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 40. Italy Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 41. Russia Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 42. Asia Pacific Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 43. Asia Pacific Furosemide API Consumption Market Share by Region (2020-2031)
Figure 44. China Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 45. Japan Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 46. South Korea Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 47. China Taiwan Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 48. Southeast Asia Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 49. India Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 50. Latin America, Middle East & Africa Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 51. Latin America, Middle East & Africa Furosemide API Consumption Market Share by Country (2020-2031)
Figure 52. Mexico Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 53. Brazil Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 54. Turkey Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 55. GCC Countries Furosemide API Consumption and Growth Rate (2020-2031) & (Tons)
Figure 56. Global Production Market Share of Furosemide API by Type (2020-2031)
Figure 57. Global Production Value Market Share of Furosemide API by Type (2020-2031)
Figure 58. Global Furosemide API Price (US$/Ton) by Type (2020-2031)
Figure 59. Global Production Market Share of Furosemide API by Application (2020-2031)
Figure 60. Global Production Value Market Share of Furosemide API by Application (2020-2031)
Figure 61. Global Furosemide API Price (US$/Ton) by Application (2020-2031)
Figure 62. Furosemide API Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
